The influence of orally administered docosahexaenoic acid on monoamine neurotransmitter, nerve growth factor, and brain-derived neurotrophic factor in aged mice

Pharmaceutical Biology

Volumn 47, Issue 7, 2009, Pages 584-591

  Jiang, Lihe ^a,b   Shi, Yan ^b   Long, Yin ^b   Yang, Zhirong ^b  

^a GUANGXI UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Brain derived neurotrophic factor; Cognitive ability; Docosahexaenoic acid; Monoamine neurotransmitter; Nerve growth factor

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DOCOSAHEXAENOIC ACID; DOPAMINE; NERVE GROWTH FACTOR; NORADRENALIN; SEROTONIN;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; DIET SUPPLEMENTATION; DOPAMINE BRAIN LEVEL; DRUG BRAIN LEVEL; DRUG EFFECT; DRUG MEGADOSE; ESCAPE BEHAVIOR; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; LEARNING; LOW DRUG DOSE; MEMORY; MOUSE; NONHUMAN; NORADRENALIN BRAIN LEVEL; PROTEIN EXPRESSION; SEROTONIN BRAIN LEVEL; TASK PERFORMANCE;

MUS;

EID: 77149162078     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880200902902497     Document Type: Article

References (35)

1. Acsády L, Pascual M, Rocamora N, Soriano E, Freund TF (2000): Nerve growth factor but not neurotrophin-3 is synthesized by hippocampal GABAergic neurons that project to the medial septum. Neuroscience 98: 23-31.
2. Akbar M, Calderon F, Wen Z, Kim HY (2005): Docosahexaenoic acid: A positive modulator of Akt signaling in neuronal survival. Proc Natl Acad Sic USA 102: 10858-10863.
3. Arnsten AFT, Cai JX, Murphy BL,Goldman-Rakic PS (1994): Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology 116: 143-151.
4. Barde YA (1989): Trophic factors and neuronal survival. Neuron 2: 1525-1534.
5. Barili P, De Carolis G, Zacchero D, Amenta F (1998): Sensitivity to aging of the limbic dopaminergic system: a review. Mech Ageing Devel 106: 57-92.
6. Bligh EG., Dyer WJ (1959): A rapid method of total lipid extraction and puriffcation. Can J Biochem Phys 37: 911-917.
7. Catalan J, Moriguchi T, Slotnick B, Murthy M, Greiner RS, Salem NJr (2002): Cognitive deffcits in docosahexaenoic acid-deffcient rats. Behav Neurosci 116: 1022-1031.
8. Ciccarelli R, Ballerini P, Sabatino G, Rathbone MP, D'Onofrio M, Caciagli F, Di Iorio P (2001): Involvement of astrocytes in purinemediated reparative processes in the brain. Int J Dev Neurosci 19: 395-414.
9. Conner JM, Lauterborn JC, Gall CM (1998): Anterograde transport of neurotrophin proteins in the CNS 2 A reassessment of the neurotrophic hypothesis. Rev Neurosci 9: 91-103.
10. Edwards R, Peet M, Shay J, Horrobin D (1998): Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 48: 149-155.
11. Ernfors P, Ibanez CF, Ebendal T, Olson L, Persson H (1990): Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: Developmental and topographical expression in the brain. Proc Natl Acad Sci USA 87: 5454-5458.
12. Fuji K, Hiramatsu M, Kameyama T, Nabeshima T (1993): Efiects of repeated administration of propentofylline on memory impairment produced by basal forebrain lesion in rats. Eur J Pharmaco 236: 411-417.
13. Gottfries CG (1990): Neurochemical aspects on aging and diseases with cognitive impairment. J Neurosci Res 27: 541-547.
14. Hashimoto M, Hossain S, Shimada T, Sugioka K, Yamasaki H, Fujii Y, Ishibashi Y, Oka J, Shido O (2002): Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J Neurochem 81: 1084-1091.
15. Hashimoto Y, Furukawa S, Omae F, Miyama Y, Hayashi Y (1994): Correlative regulation of nerve growth factor level and choline acetyltransferase activity by thyroxine in particular regions of infant rat brain. J Neurochem 63: 326-332.
16. Ikemoto A, Nitta A, Furukawa A, Ohishi M, Nakamura A, Fujii Y, Okuyama H (2000): Dietary n-3 fatty acid deffciency decreases nerve growth factor content in rat hippocampus. Neurosci Lett 285: 99-102.
17. Jumpsen J, Lien EL, Goh YK, Glandinin T (1997): Small changes of dietary (n-6) and (n-3) fatty acid content ratio alter phosphatidylethanolamine and phosphatidylcholine fatty acid composition during development of neuronal and glial cells in rats. J Nutr 127: 724-731.
18. Kodas E, Vancassel S, Lejeune B, Guilloteau D, Chalon S (2002): Reversibility of n-3 fatty acid deffciency-induced changes in dopaminergic neurotransmission in rats: Critical role of developmental stage. J Lipid Res 43: 1209-1219.
19. Korsching S, Auburger G, Heumann R, Scott J, Thoenen H (1985): Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. EMBO J 4: 1389-1393.
20. Lee JI, Chang CK, Liu IM, Chi TC, Yu HJ, Cheng JT (2001): Changes in endogeneous monoamines in aged rats. Clin Exper Pharmacol Physiol 28: 285-289.
21. Levi-Montalcini R (1987): The nerve growth factor 35 years later. Science 237: 1154-1162.
22. Lim SY, Suzuki H (2002): Dose-response efiect of docosahexaenoic acid ethyl ester on maze behavior and brain fatty acid composition in adult mice. Int J Vitam Nutr Res 72: 77-84.
23. Logan AC (2003): Neurobehavioral aspects of omega-3 fatty acids: Possible mechanisms and therapeutic value in major depression. Altern Med Rev 8: 410-425.
24. Luine V, Bowling D, Hearns M (1990): Spatial memory deffcits in aged rats: contributions of monoaminergic systems. Brain Res 537: 271-278.
25. McGahon BM, Martin DS, Horrobin DF, Lynch MA (1999): Age-related changes in synaptic function: Analysis of the efiect of dietary supplementation with omega-3 fatty acids. Neuroscience 94: 305-314.
26. Miguez JM, Aldegunde M, Paz-Valinas L, Recio J, Sanchez-Barcelo E (1999): Selective changes in the contents of noradrenaline, dopamine and serotonin in rat brain areas during aging. J Neural Transm 106: 1089-1098.
27. Minami M, Kimura S, Endo T, Hamaue N, Hirafuji M, Togashi H, Matsumoto M, Yoshioka M, Sato H, Watanabe S, Kobayashi T, Okuyama H (1997): Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats. Pharmacol Biochem Behav 58: 1123-1129.
28. Mojca-Juric DM, Milklic S, Carman-Krzan M (2006): Monoaminergic neuronal activity upregulates BDNF synthesis cultured neonatal rat astrocytes. Brain Res 1108: 54-62.
29. Nitta A, Furukawa Y, Hayashi K, Hiramatsu M, Kamayama T, Hasegawa T, Nabeshima T (1992): Denervation of dopaminergic neurons with 6-hydroxydopamine increases nerve growth factor content in rat brain. Neurosci Lett 44: 152-156.
30. Pang PT, Teng HK, Zaitsev E, Woo NT, Sakata K, Zhen S, Teng KK, Yung WH. Hempstead BL, Lu B (2004): Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 306: 487-491.
31. Salem N Jr, Litman B, Kim HY, Gawrisch K (2001): Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 36: 945-959.
32. Suzuki H, Morikawa Y, Takahashi H (2001): Efiect of DHA oil supplementation on intelligence and visual acuity in the elderly. World Rev Nutr Diet 88: 68-71.
33. Tanila H, Taira T, Piepponen TP, Honkanen A (1994): Efiect of sex and age on brain monoamines and spatial learning in rats. Neurobiol Aging 15: 733-741.
34. Yamada K., Noda Y, Nakayama S, Komori Y, Sugihara H, Hasegawa T, Nabeshima T (1995): Role of nitric oxide in learning, and memory and in monoamine metabolism in the rat brain. Br J Pharmacol 115: 852-858.
35. Zafra F, Castren E, Thoenen H, Lindholm D (1991): Interplay between glutamate and gamma-aminobutyric acid transmitter systems in the physiological regulation of brain-derived neurotrophic factor and nerve growth factor synthesis in hippocampal neurons. Proc Natl Acad Sci USA 88: 10037-10041.